Oncogene - Table of Contents alert Volume 35 Issue 38

If you are unable to see the message below, click here to view.

Advertisement The Return of the ChIP Kit With Diagenode's ChIP Kit Customizer, buy only the kit-quality reagents that you want. Buy only what you need! Select from individual components or full kits Validated, ChIP-grade reagents including buffers, beads, controls, antibodies, and more! Learn more. TABLE OF CONTENTS Volume 35, Issue 38 (September 2016) In this issue Review Original Articles Short Communication Corrigenda Also new AOP Sign up for e-alerts Recommend to your library Web feed Subscribe Advertisement Oncogenesis is an online-only, open access journal exploring the molecular basis of cancer and related phenomena. The journal seeks to promote diverse and integrated areas of molecular biology, cell biology, oncology, and genetics. Explore the benefits of submitting your next research article. Review Top Arginine dependence of tumor cells: targeting a chink in cancer’s armor M D Patil, J Bhaumik, S Babykutty, U C Banerjee and D Fukumura Oncogene 2016 35: 4957-4972; advance online publication, April 25, 2016; 10.1038/onc.2016.37 Abstract | Full Text Original Articles Top Phosphorylation-dependent cleavage regulates von Hippel Lindau proteostasis and function P German, S Bai, X-D Liu, M Sun, L Zhou, S Kalra, X Zhang, R Minelli, K L Scott, G B Mills, E Jonasch and Z Ding Oncogene 2016 35: 4973-4980; advance online publication, March 14, 2016; 10.1038/onc.2016.40 Abstract | Full Text The Δ133p53 isoform and its mouse analogue Δ122p53 promote invasion and metastasis involving pro-inflammatory molecules interleukin-6 and CCL2 I Roth, H Campbell, C Rubio, C Vennin, M Wilson, A Wiles, G Williams, A Woolley, P Timpson, M V Berridge, N Fleming, M Baird and A W Braithwaite Oncogene 2016 35: 4981-4989; advance online publication, March 21, 2016; 10.1038/onc.2016.45 Abstract | Full Text Topoisomerase IIα mediates TCF-dependent epithelial–mesenchymal transition in colon cancer OPEN Q Zhou, A D Abraham, L Li, A Babalmorad, S Bagby, J J Arcaroli, R J Hansen, F A Valeriote, D L Gustafson, J Schaack, W A Messersmith and D V LaBarbera Oncogene 2016 35: 4990-4999; advance online publication, March 7, 2016; 10.1038/onc.2016.29 Abstract | Full Text RNA-binding motif protein 47 inhibits Nrf2 activity to suppress tumor growth in lung adenocarcinoma OPEN T Sakurai, K Isogaya, S Sakai, M Morikawa, Y Morishita, S Ehata, K Miyazono and D Koinuma Oncogene 2016 35: 5000-5009; advance online publication, February 29, 2016; 10.1038/onc.2016.35 Abstract | Full Text Effects of Kras activation and Pten deletion alone or in combination on MUC1 biology and epithelial-to-mesenchymal transition in ovarian cancer L Zhang, T Ma, J Brozick, K Babalola, R Budiu, G Tseng and A M Vlad Oncogene 2016 35: 5010-5020; advance online publication, March 14, 2016; 10.1038/onc.2016.53 Abstract | Full Text The impact of chromosomal translocation locus and fusion oncogene coding sequence in synovial sarcomagenesis K B Jones, J J Barrott, M Xie, M Haldar, H Jin, J-F Zhu, M J Monument, T L Mosbruger, E M Langer, R L Randall, R K Wilson, B R Cairns, L Ding and M R Capecchi Oncogene 2016 35: 5021-5032; advance online publication, March 7, 2016; 10.1038/onc.2016.38 Abstract | Full Text The PLA2R1-JAK2 pathway upregulates ERRα and its mitochondrial program to exert tumor-suppressive action A Griveau, G Devailly, L Eberst, N Navaratnam, B Le Calvé, M Ferrand, P Faull, A Augert, R Dante, J M Vanacker, D Vindrieux and D Bernard Oncogene 2016 35: 5033-5042; advance online publication, April 4, 2016; 10.1038/onc.2016.43 Abstract | Full Text The heparan sulfate sulfotransferase 3-OST3A (HS3ST3A) is a novel tumor regulator and a prognostic marker in breast cancer X Mao, C Gauche, M W H Coughtrie, C Bui, S Gulberti, F Merhi-Soussi, N Ramalanjaona, I Bertin-Jung, A Diot, D Dumas, N De Freitas Caires, A M Thompson, J-C Bourdon, M Ouzzine and S Fournel-Gigleux Oncogene 2016 35: 5043-5055; advance online publication, April 4, 2016; 10.1038/onc.2016.44 Abstract | Full Text CD82 suppresses CD44 alternative splicing-dependent melanoma metastasis by mediating U2AF2 ubiquitination and degradation P Zhang, S Feng, G Liu, H Wang, A Fu, H Zhu, Q Ren, B Wang, X Xu, H Bai and C Dong Oncogene 2016 35: 5056-5069; advance online publication, April 4, 2016; 10.1038/onc.2016.67 Abstract | Full Text Short Communication Top Hypoxia and MITF regulate KIT oncogenic properties in melanocytes F Laugier, J Delyon, J André, A Bensussan and N Dumaz Oncogene 2016 35: 5070-5077; advance online publication, March 14, 2016; 10.1038/onc.2016.39 Abstract | Full Text Corrigenda Top miR-625 suppresses tumour migration and invasion by targeting IGF2BP1 in hepatocellular carcinoma X Zhou, C Z Zhang, S-X Lu, G G Chen, L-Z Li, L-L Liu, C Yi, J Fu, W Hu, J-M Wen and J-P Yun Oncogene 2016 35: 5078; advance online publication, August 8, 2016; 10.1038/onc.2016.61 Full Text Identification of latent biomarkers in hepatocellular carcinoma by ultra-deep whole-transcriptome sequencing K-T Lin, Y-J Shann, G-Y Chau, C-N Hsu and C-YF Huang Oncogene 2016 35: 5078; advance online publication, August 1, 2016; 10.1038/onc.2016.62 Full Text Advertisement Have you checked out the Oncogene top 10? We have a continuously updated list of articles that highlight what has been downloaded by our website users over the past 7 days. Take a look as you may have missed out on something that could help with your research!  Click here to view the top 10  Natureevents is a fully searchable, multi-disciplinary database designed to maximise exposure for events organisers. The contents of the Natureevents Directory are now live. The digital version is available here. Find the latest scientific conferences, courses, meetings and symposia on natureevents.com. For event advertising opportunities across the Nature Publishing Group portfolio please contact natureevents@nature.com More Nature Events Please note that you need to be a subscriber or site-licence holder to enjoy full-text access to Oncogene. In order to do so, please purchase a subscription. You have been sent this Table of Contents Alert because you have opted in to receive it. You can change or discontinue your e-mail alerts at any time, by modifying your preferences on your nature.com account at: www.nature.com/nams/svc/myaccount (You will need to log in to be recognised as a nature.com registrant). For further technical assistance, please contact our registration department. For print subscription enquiries, please contact our subscription department. For other enquiries, please contact our customer feedback department. Nature Publishing Group |One New York Plaza, Suite 4500 | New York | NY 10004-1562 | USA Nature Publishing Group's worldwide offices: London - Paris - Munich - New Delhi - Tokyo - Melbourne San Diego - San Francisco - Washington - New York - Boston Macmillan Publishers Limited is a company incorporated in England and Wales under company number 785998 and whose registered office is located at The Campus, 4 Crinan Street, London, N1 9XW. © 2016 Nature Publishing Group, a division of Macmillan Publishers Limited. All Rights Reserved.